Back to AI Alyeska Investment Group, L.P.

TEVATEVA
14 quarters

Position history for AIAlyeska Investment Group, L.P.'s holdings in TEVA PHARMACEUTICAL-SP ADR

Yes. Alyeska Investment Group holds 6,257,579 shares of TEVA (Teva Pharmaceutical), worth $212M, as of its Q2 2026 13F filing. It increased the position by 738,549 shares (+13.4%) from Q1 2026. Alyeska Investment Group has held TEVA since Q1 2023, across 14 quarterly 13F filings. TEVA is 0.5% of Alyeska Investment Group's reported 13F portfolio.

Current Value

$212M

Current Shares

6.3M

Total Value Change

+$204.9M

Total Shares Change

+5.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.3M
+13.4%
$212M0.5%$33.88
49
2026-Q1
Increased
5.5M
+56.1%
$166.2M0.5%$30.12
51
2025-Q4
Decreased
3.5M
-40.8%
$110.4M0.3%$31.21
0
2025-Q3
Increased
6M
+145.9%
$120.7M0.4%$20.20
58
2025-Q2
Decreased
2.4M
-24.6%
$40.7M0.1%$16.76
0
2025-Q1
Decreased
3.2M
-11.4%
$49.6M0.2%$15.37
0
2024-Q4
Increased
3.6M
+0.5%
$80.3M0.3%$22.04
36
2024-Q3
Decreased
3.6M
-5.3%
$65.3M0.3%$18.02
0
2024-Q2
Decreased
3.8M
-39.7%
$62.2M0.4%$16.25
0
2024-Q1
Increased
6.3M
+16.2%
$89.5M0.6%$14.11
49
2023-Q4
Decreased
5.5M
-15.5%
$57M0.4%$10.44
0
2023-Q3
Increased
6.5M
+330.8%
$65.9M0.4%$10.20
57
2023-Q2
Increased
1.5M
+87.5%
$11.3M0.1%$7.53
43
2023-Q1
New
800,000
-
$7.1M0.1%$8.85
38

Other major holders of TEVA: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used